NeuCyber NeuroTech develops implantable brain-computer interface systems for patients with severe motor impairment. The company is affiliated with the Chinese Institute for Brain Research and is part of Beijing’s state-backed effort to build a domestic BCI industry.

Its lead system, Beinao-1, is a semi-invasive wireless BCI that places electrodes on the dura mater. The system uses flexible cortical electrodes and decoding algorithms to translate neural activity into assistive outputs, including robotic-arm control, computer interaction, and communication functions.

NeuCyber has reported multiple early human implantations and plans to expand Beinao-1 trials to 50 patients in 2026. The company is best understood as a Chinese clinical-stage BCI developer using a cortical-surface implant strategy for assistive control and motor-function restoration.